INS and metabolic syndrome: To manage blood glucose levels, patients with T1DM need lifelong insulin therapy.[7] In patients with T1DM-associated dyslipidemia, low-density lipoprotein cholesterol (LDL-C), triglycerides, and total cholesterol levels are often elevated, while high-density lipoprotein cholesterol (HDL-C) levels are typically decreased.[8,9] These anomalies are worsened by poor glycemic management, which increases the risk of cardiovascular disease (CVD).[9]